Compare IMNM & CDZIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMNM | CDZIP |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | 25 |
| Industry | Medicinal Chemicals and Botanical Products | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | N/A |
| IPO Year | 2020 | N/A |
| Metric | IMNM | CDZIP |
|---|---|---|
| Price | $21.68 | $19.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $31.44 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,679,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.53 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.15 | N/A |
| 52 Week High | $25.30 | N/A |
| Indicator | IMNM | CDZIP |
|---|---|---|
| Relative Strength Index (RSI) | 57.81 | 45.97 |
| Support Level | $19.37 | $19.34 |
| Resistance Level | $22.57 | $19.78 |
| Average True Range (ATR) | 1.48 | 0.14 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 44.99 | 24.14 |
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.